| Serial Number | 79208607 |
| Word Mark | E |
| Filing Date | Thursday, December 15, 2016 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, May 30, 2025 |
| Registration Number | 5603613 |
| Registration Date | Tuesday, November 13, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 28, 2018 |
| Description of Mark | The mark consists of patterns of dark and light green dots forming irregular circles, lines, and hexagons, all of which together form the letter "E"; several light green dots appear at random surrounding the "E". The color white represents the background, outlining, shading and/or transparent areas and is not part of the mark. |
| Description of the Colors Claimed | Green. |
| Goods and Services | Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for transport of therapeutic agents; pharmaceutical preparations, namely, engineered exosomes that deliver protein for genetic therapy; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, extracellular vesicle-based nucleic acid therapeutics for the prevention and treatment of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders |
| Pseudo Mark | EVOX |
| Indication of Colors claimed | The color(s) green is/are claimed as a feature of the mark. |
| Goods and Services | Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 30, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Evox Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Evox Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Evox Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, June 1, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 2, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 6, 2017 | APPLICATION FILING RECEIPT MAILED |
| Friday, June 9, 2017 | NON-FINAL ACTION WRITTEN |
| Saturday, June 10, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, June 17, 2017 | REFUSAL PROCESSED BY MPU |
| Saturday, June 17, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, December 13, 2017 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, December 13, 2017 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, December 15, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 15, 2017 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Saturday, December 16, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 2, 2017 | ASSIGNED TO EXAMINER |
| Saturday, July 8, 2017 | REFUSAL PROCESSED BY IB |
| Friday, December 15, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 30, 2018 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Wednesday, January 31, 2018 | ATTORNEY REVIEW COMPLETED |
| Thursday, February 15, 2018 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Wednesday, June 27, 2018 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, June 27, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 27, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 18, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 11, 2018 | FINAL REFUSAL WRITTEN |
| Thursday, January 11, 2018 | FINAL REFUSAL E-MAILED |
| Thursday, January 11, 2018 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, August 8, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 8, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 24, 2018 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 28, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 13, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, February 13, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, February 20, 2019 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 20, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, March 8, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Saturday, December 4, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, November 13, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, May 30, 2025 | CANCELLED SECTION 71 |
| Thursday, July 30, 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, August 8, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, August 28, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |